XML 32 R8.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash Flows From Operating Activities:      
Net Income (Loss) $ 15,363,000 $ (215,112,000) $ (249,905,000)
Adjustments to reconcile net loss to net cash and cash collateral posted to counterparties provided by (used in) operating activities:      
Net amortization of premium on Agency Securities 48,127,000 53,322,000 53,909,000
Realized gain on sale of Agency Securities, available for sale (10,952,000) (143,877,000) (9,611,000)
Credit loss expense 0 1,012,000 0
(Gain) loss on Agency Securities, trading 77,145,000 (19,557,000) 0
Loss on short sale of U.S. Treasury Securities 28,000 414,000 0
Stock based compensation 4,768,000 4,071,000 2,694,000
Changes in operating assets and liabilities:      
Increase (decrease) in accrued interest receivable 2,263,000 21,828,000 (12,443,000)
Increase (decrease) in prepaid and other assets 883,000 7,074,000 (1,690,000)
Change in derivatives, at fair value (134,704,000) (100,692,000) 134,631,000
Increase (decrease) in accrued interest payable- repurchase agreements (681,000) (30,307,000) 21,664,000
Increase (decrease) in accounts payable and other accrued expenses 156,000 (1,019,000) (821,000)
Net cash and cash collateral posted to counterparties provided by (used in) operating activities 11,738,000 (257,824,000) (40,717,000)
Cash Flows From Investing Activities:      
Purchases of Agency Securities (1,265,942,000) (5,838,937,000) (8,937,989,000)
Principal repayments of Agency Securities 870,985,000 1,217,164,000 1,701,406,000
Principal repayments of Credit Risk and Non-Agency Securities 0 45,766,000 53,641,000
Proceeds from sales of Agency Securities 980,380,000 10,959,587,000 2,894,339,000
Disbursements on reverse repurchase agreements (391,125,000) (858,156,000) 0
Receipts from reverse repurchase agreements 391,125,000 858,156,000 0
Increase (decrease) in cash collateral posted by counterparties 126,356,000 29,746,000 (82,255,000)
Net cash and cash collateral posted to counterparties provided by (used in) investing activities 503,576,000 7,085,728,000 (4,389,771,000)
Cash Flows From Financing Activities:      
Issuance of common stock, net of expenses 328,780,000 54,575,000 321,860,000
Proceeds from repurchase agreements 27,238,071,000 67,986,298,000 173,216,266,000
Principal repayments on repurchase agreements (27,826,099,000) (74,804,780,000) (168,899,370,000)
Common stock dividends paid (96,630,000) (75,486,000) (124,477,000)
Common stock repurchased, net 0 (777,000) (16,965,000)
Net cash and cash collateral posted to counterparties provided by (used in) financing activities (330,766,000) (6,929,402,000) 4,471,455,000
Net increase (decrease) in cash and cash collateral posted to counterparties 184,548,000 (101,498,000) 40,967,000
Cash and cash collateral posted to counterparties - beginning of year 171,668,000 273,166,000 232,199,000
Cash and cash collateral posted to counterparties - end of year 356,216,000 171,668,000 273,166,000
Supplemental Disclosure:      
Cash paid during the year for interest 21,262,000 183,365,000 425,746,000
Non-Cash Investing and Financing Activities      
Payable for unsettled purchases 0 0 (358,712,000)
Net unrealized gain (loss) on available for sale Agency Securities (61,106,000) (33,577,000) 408,954,000
Amounts receivable for issuance of preferred stock 0 0 5,506,000
Amounts payable for common stock repurchased 0 0 (803,000)
Series A Preferred Stock      
Cash Flows From Financing Activities:      
Redemption of Preferred stock, net of expenses 0 0 (54,514,000)
Preferred dividends paid 0 0 (2,249,000)
Series B Preferred Stock      
Cash Flows From Financing Activities:      
Redemption of Preferred stock, net of expenses 0 (209,583,000) 0
Issuance of Preferred stock, net of expenses 0 0 44,289,000
Preferred dividends paid 0 (1,375,000) (13,385,000)
Series C Preferred Stock      
Cash Flows From Financing Activities:      
Issuance of Preferred stock, net of expenses 36,585,000 130,138,000 0
Preferred dividends paid (11,473,000) (8,412,000) 0
Credit Risk and Non-Agency Securities      
Adjustments to reconcile net loss to net cash and cash collateral posted to counterparties provided by (used in) operating activities:      
Amortization (accretion) 0 (2,849,000) (2,956,000)
(Gain) loss on debt securities, trading 0 189,555,000 24,396,000
Cash Flows From Investing Activities:      
Purchases of trading securities 0 (237,928,000) (138,767,000)
U.S. Treasury Securities Sold 0 889,057,000 0
Interest Only Securities      
Adjustments to reconcile net loss to net cash and cash collateral posted to counterparties provided by (used in) operating activities:      
Amortization (accretion) 0 0 1,924,000
(Gain) loss on debt securities, trading 0 0 (123,000)
Cash Flows From Investing Activities:      
U.S. Treasury Securities Sold 0 0 18,822,000
US Treasury Securities      
Adjustments to reconcile net loss to net cash and cash collateral posted to counterparties provided by (used in) operating activities:      
Amortization (accretion) (21,000) 84,000 (362,000)
(Gain) loss on debt securities, trading 9,363,000 (21,771,000) (2,024,000)
Cash Flows From Investing Activities:      
Purchases of trading securities (987,887,000) (4,621,776,000) (1,685,058,000)
U.S. Treasury Securities Sold $ 779,684,000 $ 4,643,049,000 $ 1,786,090,000